View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results...

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today reported financial results for the first quarter ended March 31, 2024, and provided recent business highlights. “We are excited about the therapeutic potential of...

 PRESS RELEASE

Guardion Health Sciences Announces

Guardion Health Sciences Announces -- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at the Upcoming Special Meeting of Stockholders on May 23, 2024 Board of Directors Urges Stockholders to Vote to Approve the Sale of the Company’s Viactiv Brand and Business and Plan of Liquidation and Dissolution If both proposals are approved, stockholders would receive one or more liquidating cash distributions, which combined are expected to repres...

 PRESS RELEASE

Horizon Bancorp, Inc. Names John R. Stewart, CFA as Chief Financial Of...

Horizon Bancorp, Inc. Names John R. Stewart, CFA as Chief Financial Officer MICHIGAN CITY, Ind., May 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”) announced today that John R. Stewart, CFA has been named Horizon’s next Executive Vice President and Chief Financial Officer (CFO). Stewart will assume the responsibilities of CFO on May 20, 2024. Stewart has 22 years of financial services experience spanning banking, investment management and corporate finance at regional banks, global investment banks and institutional asset management fi...

 PRESS RELEASE

Glacier Reports First Quarter 2024 Results

Glacier Reports First Quarter 2024 Results VANCOUVER, British Columbia, May 13, 2024 (GLOBE NEWSWIRE) -- Glacier Media Inc. (TSX: GVC) (“Glacier” or the “Company”) reported revenue and earnings for the period ended March 31, 2024. SUMMARY RESULTS (thousands of dollars) Three months ended March 31, except share and per share amounts  2024   2023      Revenue $34,750  $39,218 EBITDA (1) $(322) $(2,241)EBITDA (1) margin  (0.9%)  (5.7%)EBITDA (1) per share $(0.00) $(0.02)Capital expenditures $759  $1,077 Net loss attributable to common shareholder $(4,429) $(5,217)Net loss attributable to co...

 PRESS RELEASE

Brilliant Earth Announces Participation in 19th Annual Needham Technol...

Brilliant Earth Announces Participation in 19th Annual Needham Technology, Media, & Consumer Conference SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in the 19th Annual Needham Technology, Media, & Consumer Conference. The Company will hold virtual investor meetings throughout the day on Thursday, May 16, 2024. About Brilliant Earth  Brilliant Earth is a digitally native, omnichannel fine jew...

 PRESS RELEASE

Orchestra BioMed Reports First Quarter 2024 Financial Results and Prov...

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update Company hosting in-person R&D day event, focused on atrioventricular interval modulation (“AVIM”) therapy, including the unmet need in hypertension, mechanism of action, clinical results and design of the BACKBEAT study in New York City on June 11, 2024 NEW HOPE, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing p...

 PRESS RELEASE

RCP Fund XVIII Closes on ~$285 Million in Aggregate Capital Commitment...

RCP Fund XVIII Closes on ~$285 Million in Aggregate Capital Commitments CHICAGO, May 13, 2024 (GLOBE NEWSWIRE) -- RCP Advisors, a private equity investment firm that provides access to North American small buyout fund managers through primary funds, secondary funds, and co-investment funds, announced the final closing of RCP Fund XVIII (“Fund XVIII” or the “Fund”). The Fund closed on approximately $285 million in aggregate commitments. The Fund has a broad LP base of new and existing investors, including family offices, high-net-worth individuals, foundations, public pension plans, and en...

 PRESS RELEASE

Maui Land & Pineapple Company Reports Fiscal 2024 First Quarter Result...

Maui Land & Pineapple Company Reports Fiscal 2024 First Quarter Results Annual Meeting and Shareholder Presentation to be held virtually on May 15, 2024 at 10:00 a.m. HST KAPALUA, Hawaii, May 13, 2024 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the three month period ended March 31, 2024. The company’s annual meeting and shareholder presentation will be held virtually on May 15, 2024 at 10:00 a.m. Hawaii Standard Time, via meeting link posted on mauiland.com/investors. “Maui Land & Pineapple Company’s renewed mission to ...

 PRESS RELEASE

Allogene Therapeutics Announces Pricing of $110 million Offering of Co...

Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock SOUTH SAN FRANCISCO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced the pricing of an underwritten offering of 37,931,035 shares of its common stock at a price of $2.90 per share. The gross proceeds from this offering are expected to be approximately $110 million, before deducting the underwriting discount and commi...

 PRESS RELEASE

Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results

Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results AUSTIN, Texas, May 13, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2024, which ended March 31, 2024. Financial Highlights & Recent Developments  Astrotech’s consolidated balance sheet remains strong with $34.7 million in cash and liquid investments.Year-to-date revenue totaled $1.6 million and was generated by sales of TRACER 1000™ explosive trace detector (ETD), as well as recurring maintenance service...

 PRESS RELEASE

Ikena Oncology Reports First Quarter 2024 Financial Results and Corpor...

Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update Strong financial position with $157.3 million; runway into 2H 2026 IK-930 program on track to deliver clinical update in 2H 2024 IK-595 program continues dose escalation in patients with RAS and RAF mutant cancers BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced financial results for the first quarter ended March 31, 2024. The Company also prov...

 PRESS RELEASE

Parks! America Announces Significant Breakthrough for Registered Share...

Parks! America Announces Significant Breakthrough for Registered Shareholders PINE MOUNTAIN, Georgia, May 13, 2024 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA) (“Parks! America” or the “Company”), a leading operator of regional safari parks in the United States, today announced effective May 1, 2024, Parks! America became eligible for The Depository Transfer Corporation (“DTC”) Fast Automated Securities Transfer Program (“FAST”). The Company is now in the process of working through step-by-step procedures that will allow Parks! America shareholders to transition their paper st...

 PRESS RELEASE

Jamf Announces Launch of Secondary Offering of Common Stock by Selling...

Jamf Announces Launch of Secondary Offering of Common Stock by Selling Stockholders and Related Common Stock Repurchase MINNEAPOLIS, May 13, 2024 (GLOBE NEWSWIRE) -- Jamf (Nasdaq: JAMF), the standard in managing and securing Apple at work, today announced the commencement of an underwritten public offering (the “Offering”) of its common stock by investment funds affiliated with Vista Equity Partners (the “Selling Stockholders”). The Selling Stockholders are offering 8,956,522 shares of Jamf’s common stock pursuant to a registration statement on Form S-3 (the “Registration Statement”) file...

Dillard's, Inc.: Update following affirmation of Baa3 rating

Our credit view of this issuer reflects its strong liquidity and its significant financial flexibility from owned real estate, constrained by its heavy regional store concentration.

Moody's Ratings revises outlook on 412 US local government issuers fro...

Moody's Ratings (Moody's) has revised the outlook on 412 US local government issuers from stable to no outlook (NOO). The issuer and long-term underlying debt instrument ratings have been affirmed. RATINGS RATIONALE Please click on this link /viewresearchdoc.aspx?docid=PBM_P...

Moody's Ratings upgrades Quest Diagnostics' senior unsecured debt rati...

Moody's Ratings (Moody's) upgraded the senior unsecured debt ratings of Quest Diagnostics Incorporated ("Quest") to Baa1 from Baa2. Moody's also upgraded the rating on the company's senior unsecured shelf registration to (P)Baa1 from (P) Baa2. The outlook was changed to stable from positive.        ...

 PRESS RELEASE

MaxLinear, Inc. Announces Financial Conference Participation for the S...

CARLSBAD, Calif.--(BUSINESS WIRE)-- MaxLinear, Inc. (Nasdaq: MXL), a leading provider of RF, analog, digital and mixed-signal integrated circuits, today announced that it will participate in the following financial conferences in the second quarter of 2024: Stifel 2024 Cross Sector Insight Conference in Boston on June 5th. MaxLinear’s presentation is scheduled for 1:15 p.m. ET. A webcast of the session will be available at . Northland Securities Growth Conference 2024 on June 25th About MaxLinear, Inc. MaxLinear, Inc. (Nasdaq:MXL) is a leading provider of radio frequency (RF), analo...

 PRESS RELEASE

Farmers & Merchants Bancorp (FMCB) ranked #6 on Forbes Magazine’s List...

Farmers & Merchants Bancorp (FMCB) ranked #6 on Forbes Magazine’s List of “America’s Best Banks” for 2023 LODI, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Farmers & Merchants Bancorp (OTCQX: FMCB), the parent company of Farmers & Merchants Bank of Central California (F&M Bank), is pleased to announce that F&M Bank has been ranked 6th on Forbes Magazine’s list of "America’s Best Banks" in 2023. Forbes’ annual “America’s Best Banks” list looks at ten metrics measuring growth, credit quality, profitability, and capital for the 2023 calendar year, as well as stock performance in the 12 month...

 PRESS RELEASE

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter 2024 on Tuesday, May 14, 2024, after market close. Company management will host a ...

 PRESS RELEASE

Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2024 le ...

Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2024 le 14 Mai 2024 Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2024 le 14 Mai 2024 Mont-Saint-Guibert, Belgique – 13 mai 2024, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») opère dans le secteur des technologies médicales et se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La Société a a annoncé aujourd'hui qu’elle publiera ses résultats financiers po...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch